ZA200108404B - Cyclobutenedione compounds, a process for their preparation and pharmaceutical compositions containing them. - Google Patents
Cyclobutenedione compounds, a process for their preparation and pharmaceutical compositions containing them.Info
- Publication number
- ZA200108404B ZA200108404B ZA200108404A ZA200108404A ZA200108404B ZA 200108404 B ZA200108404 B ZA 200108404B ZA 200108404 A ZA200108404 A ZA 200108404A ZA 200108404 A ZA200108404 A ZA 200108404A ZA 200108404 B ZA200108404 B ZA 200108404B
- Authority
- ZA
- South Africa
- Prior art keywords
- preparation
- pharmaceutical compositions
- compositions containing
- cyclobutenedione
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0013072A FR2815345B1 (fr) | 2000-10-12 | 2000-10-12 | Nouveaux derives de cyclobutene-dione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200108404B true ZA200108404B (en) | 2002-06-05 |
Family
ID=8855275
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200108404A ZA200108404B (en) | 2000-10-12 | 2001-10-12 | Cyclobutenedione compounds, a process for their preparation and pharmaceutical compositions containing them. |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US6696469B2 (hu) |
| EP (1) | EP1197485B1 (hu) |
| JP (1) | JP3566685B2 (hu) |
| KR (1) | KR100511132B1 (hu) |
| CN (1) | CN1274675C (hu) |
| AR (1) | AR033683A1 (hu) |
| AT (1) | ATE273276T1 (hu) |
| AU (1) | AU781002B2 (hu) |
| BR (1) | BR0104471A (hu) |
| CA (1) | CA2358724C (hu) |
| DE (1) | DE60104791T2 (hu) |
| DK (1) | DK1197485T3 (hu) |
| EA (1) | EA004268B1 (hu) |
| ES (1) | ES2227092T3 (hu) |
| FR (1) | FR2815345B1 (hu) |
| HK (1) | HK1045517B (hu) |
| HU (1) | HUP0104272A3 (hu) |
| MX (1) | MXPA01010049A (hu) |
| NO (1) | NO320702B1 (hu) |
| NZ (1) | NZ514758A (hu) |
| PL (1) | PL350104A1 (hu) |
| PT (1) | PT1197485E (hu) |
| SI (1) | SI1197485T1 (hu) |
| TR (1) | TR200402070T4 (hu) |
| ZA (1) | ZA200108404B (hu) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2570693A1 (en) | 2004-06-17 | 2006-01-26 | Wyeth | Processes for preparing gonadotropin releasing hormone receptor antagonists |
| JP2008503469A (ja) | 2004-06-17 | 2008-02-07 | ワイス | ゴナドトロピン放出ホルモン受容体アンタゴニスト |
| JP2008520732A (ja) * | 2004-11-23 | 2008-06-19 | ワイス | ゴナドトロピン放出ホルモン受容体アンタゴニスト |
| ATE432921T1 (de) * | 2004-12-23 | 2009-06-15 | Gpc Biotech Ag | Quadratsäurederivate mit antiproliferativer wirkung |
| US7582634B2 (en) | 2005-02-18 | 2009-09-01 | Wyeth | 7-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor |
| US7534796B2 (en) | 2005-02-18 | 2009-05-19 | Wyeth | Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor |
| US7538113B2 (en) | 2005-02-18 | 2009-05-26 | Wyeth | 4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor |
| US20060189619A1 (en) * | 2005-02-24 | 2006-08-24 | Wyeth | 3-({4-[2-(4-Tert-butylphenyl)-1h-benzimidazol-4-yl]piperazin-1-yl}methyl)pyrido[2,3-b]]pyrazi ne compounds |
| US7531542B2 (en) | 2005-05-18 | 2009-05-12 | Wyeth | Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor |
| US7582636B2 (en) | 2005-05-26 | 2009-09-01 | Wyeth | Piperazinylimidazopyridine and piperazinyltriazolopyridine antagonists of Gonadotropin Releasing Hormone receptor |
| US8450348B2 (en) * | 2007-02-21 | 2013-05-28 | Forma Tm, Llc | Derivatives of squaric acid with anti-proliferative activity |
| MX2010014310A (es) | 2008-06-24 | 2011-02-15 | Topotarget As | Derivados de acido escuarico como inhibidores de la nicotinamida. |
| CN103842330B (zh) | 2011-09-02 | 2016-10-19 | 诺华股份有限公司 | 抗炎的取代的环丁烯二酮化合物的胆碱盐 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69911980T2 (de) * | 1998-08-21 | 2004-09-09 | Smithkline Beecham P.L.C., Brentford | Pyrimidinonderivate zur behandlung von atheroscleros |
| JP2002532457A (ja) * | 1998-12-14 | 2002-10-02 | アメリカン・ホーム・プロダクツ・コーポレイション | Ｖｌａ−４により仲介される白血球接着を阻害する３，４−ジアミノ−３−シクロブテン−１，２−ジオン誘導体 |
| US6432960B2 (en) * | 2000-05-10 | 2002-08-13 | Bristol-Myers Squibb Company | Squarate derivatives of dihydropyridine NPY antagonists |
-
2000
- 2000-10-12 FR FR0013072A patent/FR2815345B1/fr not_active Expired - Fee Related
-
2001
- 2001-10-05 MX MXPA01010049A patent/MXPA01010049A/es active IP Right Grant
- 2001-10-09 JP JP2001311565A patent/JP3566685B2/ja not_active Expired - Fee Related
- 2001-10-09 BR BR0104471-0A patent/BR0104471A/pt not_active IP Right Cessation
- 2001-10-11 NO NO20014945A patent/NO320702B1/no not_active IP Right Cessation
- 2001-10-11 DK DK01402623T patent/DK1197485T3/da active
- 2001-10-11 ES ES01402623T patent/ES2227092T3/es not_active Expired - Lifetime
- 2001-10-11 AR ARP010104769A patent/AR033683A1/es unknown
- 2001-10-11 SI SI200130164T patent/SI1197485T1/xx unknown
- 2001-10-11 TR TR2004/02070T patent/TR200402070T4/xx unknown
- 2001-10-11 CA CA002358724A patent/CA2358724C/fr not_active Expired - Fee Related
- 2001-10-11 DE DE60104791T patent/DE60104791T2/de not_active Expired - Fee Related
- 2001-10-11 AT AT01402623T patent/ATE273276T1/de not_active IP Right Cessation
- 2001-10-11 NZ NZ514758A patent/NZ514758A/xx unknown
- 2001-10-11 PT PT01402623T patent/PT1197485E/pt unknown
- 2001-10-11 EP EP01402623A patent/EP1197485B1/fr not_active Expired - Lifetime
- 2001-10-12 HU HU0104272A patent/HUP0104272A3/hu unknown
- 2001-10-12 US US09/976,572 patent/US6696469B2/en not_active Expired - Fee Related
- 2001-10-12 CN CNB011412968A patent/CN1274675C/zh not_active Expired - Fee Related
- 2001-10-12 KR KR10-2001-0062988A patent/KR100511132B1/ko not_active IP Right Cessation
- 2001-10-12 AU AU79386/01A patent/AU781002B2/en not_active Ceased
- 2001-10-12 EA EA200100969A patent/EA004268B1/ru unknown
- 2001-10-12 PL PL01350104A patent/PL350104A1/xx not_active Application Discontinuation
- 2001-10-12 ZA ZA200108404A patent/ZA200108404B/xx unknown
-
2002
- 2002-09-26 HK HK02107053.7A patent/HK1045517B/zh not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200203867B (en) | alpha-Amino acids compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| HK1050357A1 (en) | New-amino acid sulphonyl compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| ZA200105394B (en) | Diphenylurea compounds, a process for their preparation and pharmaceutical composition containing them. | |
| MXPA02007080A (es) | Compuestos novedosos que tienen actividades hipolidemicas e hipocolesterolemicas, proceso para su preparacion y composiciones farmaceuticas que los contienen. | |
| ZA200100864B (en) | Piperidine-4-sulphonamides compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| ZA200108404B (en) | Cyclobutenedione compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| PL359373A1 (en) | New substituted phthalides, a process for their preparation and pharmaceutical compositions containing them | |
| HK1038912A1 (en) | New benzenesulphonamide compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| ZA200105300B (en) | 1,1- and 1,2-disubstituted cyclopropane compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| HK1047100A1 (en) | New metalloprotease inhibitors, a process for their preparation and pharmaceutical compositions containing them. | |
| HK1050682A1 (en) | New octahydro-2h-pyridoÄ1,2-aÜpyrazine compounds, a process for their preparation and pharmaceuticalcompositions containing them. | |
| HK1049159A1 (en) | New indenoindolone compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| HK1049000A1 (en) | New isoindoloindolone compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| ZA200205598B (en) | Benzenesulphonamide compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| HK1042094A1 (en) | New benzothiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| ZA200110314B (en) | Bicyclic amino-pyrazinones compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| ZA200205666B (en) | N-benzylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| ZA200103065B (en) | Heterocycloalkylbenzocyclobutane and heteroarylbenzocyclobutane compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| HK1053646A1 (en) | BenzoÄBÜpyranoÄ3,2-HÜacridin-7-one compounds, a process for their preparation and pharmaceutical compositions containing them | |
| ZA200103064B (en) | Cyclobutaindolecarboxamide compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| ZA200204757B (en) | Indenoidolone compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| HK1048471A1 (en) | Cycloheptene compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| ZA200203086B (en) | Pyrimidin-4-one compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| ZA200101338B (en) | 6-sulphamoyl-3-quinolylphosphonic acid compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| ZA200205597B (en) | Benzenesulphonamide compounds, a process for their preparation and pharmaceutical compositions containing them. |